- Home
- MSGS vs TFX Comparison
MSGS vs TFX Comparison
Compare MSGS & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSGS | TFX |
|---|---|---|
| Founded | 1879 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MSGS | TFX |
|---|---|---|
| Price | $260.54 | $121.96 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 10 |
| Target Price | ★ $261.33 | $139.88 |
| AVG Volume (30 Days) | 177.3K | ★ 745.2K |
| Earning Date | 02-03-2026 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.11% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,025,367,000.00 | ★ $3,189,988,000.00 |
| Revenue This Year | N/A | $9.90 |
| Revenue Next Year | $4.90 | $10.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.42 |
| 52 Week Low | $173.26 | $102.58 |
| 52 Week High | $261.65 | $185.94 |
Technical Indicators
Market Signals| Indicator | MSGS | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 76.11 | 50.11 |
| Support Level | $256.50 | $120.77 |
| Resistance Level | $261.65 | $123.55 |
| Average True Range (ATR) | 6.62 | 3.40 |
| MACD | 2.22 | -0.48 |
| Stochastic Oscillator | 96.97 | 8.71 |
Price Performance
Historical ComparisonAbout MSGS Madison Square Garden Sports Corp. (New)
Madison Square Garden Sports Corp owns and operates a portfolio of assets featuring some of the recognized sports teams, including the Knicks of the NBA and the Rangers of the NHL. It generates revenue from several sources: ticket sales and a portion of suite rental fees at The Garden and others. It has one operating and reportable segment and one reporting unit for goodwill impairment testing purposes.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.